Merck of Germany's Hunt For MS BTKi Partner Boosted By Evobrutinib Data

nerve cells, concept for neurodegenerative and neurological disease
Merck KGaA Says Latest Strong Evobrutinib MS Data Will Help With Partnering Its BTKi • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Clinical Trials

More from R&D